The prognosis analysis demonstrates that higher expression of LIF had a poorer relapse free survival in breast cancer patients (Fig. 7b), suggesting that LIF could be a prognostic marker for poor prognosis of breast cancer patients. The gene discussed is LIF; the disease is breast cancer.